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Abstract
Background—Therapeutic hypothermia (TH) is the standard of care for neonates with hypoxic-
ischemic encephalopathy but is not fully protective in the clinical setting. Hypoxia-ischemia (HI) 
may cause white matter injury (WMI), leading to neurological and cognitive dysfunction.
Methods—P9 mice were subjected to HI as previously described. Pups underwent 3.5 hours of 
systemic hypothermia or normothermia. Cresyl violet and Perl’s iron stain for histopathological 
scoring of brain sections was completed blindly on all brains. Immunocytochemical (ICC) staining 
for myelin basic protein (MBP), microglia (Iba1), and astrocytes (GFAP) was performed on 
adjacent sections. Volumetric measurements of MBP coverage were used for quantitative analysis 
of white matter.
Results—TH provided neuroprotection by injury scoring for the entire group (n=44) (p<0.0002). 
ICC analysis of a subset of brains showed that the lateral caudate was protected from WMI 
(p<0.05). Analysis revealed decreased GFAP and Iba1 staining in hippocampal regions, mostly 
CA2/CA3. GFAP and Iba1directly correlated with injury scores of normothermic brains.
Conclusions—TH reduced injury and qualitative data suggest that hippocampus and lateral 
caudate are protected from HI. Mildly injured brains may better show the benefits of TH. Overall 
these data indicate regional differences in WMI susceptibility and inflammation in a P9 murine HI 
model.
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Neonatal hypoxic-ischemia (HI) treated with hypothermia has become a standard of care for 
infants. Hypoxic-ischemia encephalopathy (HIE) occurs in 3–5 per 1,000 live births and 
produces a high morbidity rate, severe/long-term neurological and cognitive deficits with 
high outcomes in cerebral palsy, epilepsy and mental retardation (1). However, no therapy 
completely protects against neonatal HIE, therefore opportunities exist to continue to 
explore additional agents (2). Therapeutic hypothermia (TH) has been shown to decrease the 
mortality rate and display neuroprotection in infants with neonatal HIE (3–5). There have 
been many mechanisms implicated in the effects of hypothermic therapy which include 
suppression of apoptosis, decreased inflammation, reduction in excitatory amino acids 
(EAA), decreased reactive oxygen species (ROS), and a reduced cerebral metabolic rate (6).
A previous study using P7 rats investigating the use of hypothermia and erythropoietin 
suggested that slightly older animals modeled equivalent to the full-term newborn brain may 
be necessary to observe the benefits of adjuvant therapy (7). Additionally, there has been 
evidence that TH displays neuroprotection for specific regions of the brain, such as the 
hippocampus and thalamus (8). Interestingly, the results of some studies show that mildly 
injured brains may receive the benefits of TH relating to white matter injury (WMI) and 
overall neuroprotection, whereas severely injured brains do not. This trend of insufficient 
benefit from TH for severely injured brains is consistent with findings in other animal 
models (9,10,11).
The presence of white matter (WM) and appropriate axon myelination are essential to 
normal brain connectivity and development in the newborn infant (12). It has been found 
that insufficient myelination leads to neurological & cognitive dysfunction (13,14). Little 
investigation has been done on the effects of hypothermia on WMI. There is evidence 
showing mild hypoxemia in neonatal mice causes WM hypomyelination and WMI (15). 
Rodent studies of HI have shown that the developmental stage of the brain, preterm vs. term, 
at the time of injury has a major role in the underlying WMI, in part due to maturation-
dependent oligodendrocyte arrest (16).
TH neuroprotection from WMI in a full-term murine model for HI has described the 
evolution of brain injury (17). A previous TH study in sheep displayed neuroprotection from 
WMI (18). The hypothesis tested is that TH will reduce WMI in P9 neonatal mice subjected 
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to a HI insult through reduction of the glial/inflammatory response. The hypothesis is 




P9 male and female CD1 mice were subjected to focal ischemia with global hypoxia as 
previously described in the Rice-Vannucci model (19). All procedures were approved by the 
Institutional Animal Care and Use Committee (IACUC) at UCSF, in accordance with NIH 
guidelines for the Care and Use of Laboratory Animals. Ligation of the left common carotid 
artery (LCCA) was carried out. Mice were anesthetized with 3% isoflurane, balance oxygen. 
A midline incision of the neck was done to dissect and ligate the LCCA via electrical 
coagulation. Pups were returned to the dam for 1 hour following the procedure. Hypoxia was 
induced by placing pups in chambers submerged in a 37°C water bath into which an 
atmosphere of 10% oxygen, 90% nitrogen was introduced via inlet and outlet tubing 
(maintained by flow meter). Pups were removed from chambers after 50 minutes and 
returned to the dam for 1 hour.
Hypothermia
The pups were then equally separated into chambers maintained at either 30°C (n=30) or 
36.5 °C (n=24), both chambers were open to room air, for 3.5 hours of either HT or NT. One 
sentinel cooled mouse was monitored with a temperature probe. All pups also had their 
temperature monitored with an infrared thermometer (Supplemental Figure S1). Following 
cooling, the temperature in the chambers of the HT pups was gradually increased to 37°C 
over 30 min.
Histology
For histopathological examination, pups were sacrificed at P14. A lethal dose of 
pentobarbital was used for anesthesia prior to transcardiac perfusion with ice-cold 4% 
paraformaldehyde in 0.1 M PBS. Brains were removed and post-fixed overnight in the same 
solution for 4 hours, then equilibrated in 30% sucrose in 0.1 M PBS. A majority of the 
brains (n=40) were cut on a Vibratome and sequential sections (50 um) were collected for 
Nissl (cresyl violet) and Perl’s iron stains. The remaining brains (n=14, 3 sham brains not 
analyzed) were frozen, cut on a cryostat (Leica Microsystems, Wetzlar, Germany) and 20-
μm coronal sections were collected on Superfrost slides and stored at −80°C. Following 
sectioning, samples were stained with cresyl violet (Nissl stain) and dehydrated in graded 
ethanol solutions, cleared in Citrisolv (Fisher Scientific, Hampton, NH) and cover-slipped in 
Permount (Fisher Scientific).
Both cresyl violet and Perl’s iron stained sections were used for histopathological scoring of 
brain sections, which was completed blindly. Sections were assessed rostral to caudal. 
Regions scored included: anterior cortex, middle cortex, posterior cortex, caudate/striatum, 
hippocampus CA1, CA2, and CA3, and the dentate gyrus. Scores were assessed for each 
region as follows: 0 = no injury, 1 = minimal cell loss manifested by scattered shrunken 
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neurons and glia with small patches of iron deposition, 2 = moderate cell loss with infarction 
in a columnar distribution in the cortex with concomitant gliosis or shrunken hippocampus 
with cell loss throughout Sommer’s sector with corresponding iron deposition, and 3 = 
severe cell loss and gliosis with cystic infarction, for a total score of 0–24. Injury scoring 5 
days after HI was completed on P9 mice treated with either normothermia or therapeutic 
hypothermia (TH) by using cresyl-violet and Perl’s iron-stained adjacent sections 
(Supplemental Figure S2). The specimens that were used only for immunocytochemistry 
(ICC) staining were also scored.
Immunofluorescence & Image Capturing
In order to identify and quantify different cell types, 2–4 sections per region were blocked 
with 25% goat serum in PBST (0.1% Triton-X-100) + 5% BSA followed by quadruple 
staining with primary antibodies. Primary antibodies were diluted in blocking solution as 
follows: Iba1 (microglia) at [1:200] (Wako Chemicals, Richmond, VA); Myelin Basic 
Protein (MBP) at [1:1000] (Abcam Cambridge, MA); Glia fibrillary acidic protein (GFAP) 
at [1:2000] (Thermo Fisher Scientific, Rockford, IL). Slides were incubated with primary 
antibodies overnight at 4°C followed by washing and incubation with species-specific 
secondary antibodies were applied at a dilution of [1:200]: Alexa Fluor 568, 488, 647 and 
350 (all Life Technologies Eugene, OR). A final washing was done and then the slides were 
mounted with a coverslip using ProLong® Gold antifade mountant (Life Technologies).
Image capturing and analysis were completed blinded using Volocity Software, a confocal-
like laser-free technology. For data analysis, z-stacks of stained sections were captured at 
5μm intervals at 10x (Zeiss Axiovert 100 equipped with Openlab Software, Improvision, 
Coventry UK). Captured images focused anatomically on the lateral caudate (which 
included a section of corpus callosum), medial caudate, hippocampus CA1 with dentate 
gyrus, and hippocampal regions CA2 and CA3. Volume coverage was analyzed for white 
matter (MBP), astroglia (GFAP) and microglia (Iba1) using an automated protocol for a 
signal intensity threshold (1.5–2.0 SD background in channels) for the caudate (position 
336–353) and hippocampus (position 235–270) according to the Allen Brain Atlas of P14 
brain strain C57BL/6J.
Statistical Analysis
Injury scores between normothermic and hypothermic groups were compared by Mann-
Whitney test. Analysis was performed with Prism 6.0 (GraphPad Software, La Jolla, CA).
Regional data for the summation of volumes of MBP, GFAP, and Iba1 was done and 
normalized using the ratio of intact ipsilateral tissue to intact contralateral hemisphere tissue. 
Data comparing HI treated with normothermia and HI treated with hypothermia was 
conducted using an unpaired t-test to determine statistical significance.
Data was compared according to degree of injury (Mild = 0–8; Moderate = 8–16; Severe 
=16–24). The raw volumetric data of MBP, GFAP and Iba1 was plotted against injury score 
of normothermic and hypothermic brain’s caudate and hippocampal regions. Data collected 
from the medial and lateral caudate were combined, and the data from the hippocampus DG, 
CA1, CA2 and CA3 were combined. Correlation coefficients were calculated using the 
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Pearson correlation coefficients test to determine the relationship between injury score with 
inflammation and white matter injury.
Results
Histopathological Analysis
Analysis of all available brain samples showed that TH provides neuroprotection, as 
determined by injury scoring (Figure 1). The protection was seen in all regions analyzed: 
cortex (p=0.0002); hippocampus (p=0.0006); and caudate (p=0.01). There were no sex 
differences in injury severity: NT male vs. NT female (n=10 each), p=0.16; HT male (n=13) 
vs. HT female (n=12), p=1.0. There was also no difference in incidence of mortality between 
groups: 4 NT and 5 HT died, p=1.0 by Fisher’s exact test.
Volumetric Immunocytochemistry Analysis
ICC volumetric analysis showed that compared to normothermic brains (Figure 2a, Figure 
3a), WMI was less in the ipsilateral caudate following TH (Figure 2b, Figure 3b). The lateral 
caudate was significantly protected from WMI (p<0.05) with TH (Figure 3c) but there were 
no significant differences in GFAP or Iba1 volume. Volumetric analysis of the medial 
caudate showed that TH provides a wide range of protection from WMI, and although 
significance could not be determined from quantitative imaging data, smaller MBP volumes 
suggest that TH plays a role in protection from WMI in the medial caudate (Figure 2c). 
Further, the medial caudate qualitative data of GFAP and Iba1 (Figure 2a, b, c), also shows 
that TH provides observable differences in imaging data compared to normothermia. Data 
collected from the hippocampal region CA1 and dentate gyrus showed no differences in 
MBP, GFAP or Iba1 volumes between normothermic and TH-treated groups (Figure 4c). 
However, qualitative imaging data again suggests that TH may play a role in preservation of 
WM and an overall decrease in features of inflammation (Figure 4a, b). Analysis of ICC 
sections showed decreased GFAP and Iba1 staining in the ipsilateral hippocampal regions, 
mostly CA2/CA3 treated with TH compared to normothermia (Figure 5a, b, c). However, the 
MBP staining did not show that the WM is protected in this region.
Relationship between Injury, WMI and Inflammation
White matter and injury score correlations in TH-treated brains are suggestive of some WMI 
protection in the caudate (Figure 6a) when the injury score is mild (r = −0.9077) compared 
to normothermic treated (r = −0.4668). Similarly, the caudate displayed correlation between 
injury score and inflammation in normothermic brains (Figure 6b, c) for GFAP (r = 0.9128) 
and Iba1 (r = 0.7524). Caudate hypothermia-treated correlation coefficients of GFAP (r = 
0.2448) and Iba1 (r = 0.4958) also displayed a positive correlation with injury score, but not 
as strong as the normothermic treated. The hippocampus (Figure 6d) shows a negligible 
difference in the correlation between WMI and injury score of normothermia and 
hypothermia treated brains.
Normothermic brains displayed a strong positive correlation between injury score and 
inflammation in the hippocampal region (Figure 6e, f) when compared to TH-treated mice. 
GFAP assessed in the normothermic treated brains showed a positive correlation (r = 
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0.4062), compared to TH treatment, which showed a negative correlation (r = −0.2900). Iba1 
coverage assessed in the normothermic treated brains showed a positive correlation (r = 
0.4475) compared to the TH-treated which showed a negative correlation (r = −0.3770). In 
normothermic brains the degree of inflammation directly correlated with the injury score of 
the normothermic brains. In comparison, TH-treatment displayed protection from 
inflammation in the hippocampal region according to the negative correlation coefficients 
(Figure 6e, f).
Discussion
This study establishes that TH in a full-term murine HI model provides overall brain 
protection and specifically WM protection in specific regions. The study also shows a direct 
correlation between the degree of HI injury and glial response. Additionally, we demonstrate 
that TH neuroprotection is region dependent and provides protection from WMI in mildly 
injured brains.
WM is essential to brain connectivity and proper maturation in the neonatal brain (12). In 
the rodent brain, WM maturation peaks during the second–third weeks of life, thus, distorted 
myelination or altered composition and function of the WM after HI in P9 mice would 
adversely affect repair (13, 14). HI causes significant damage to the developing brain, 
including WMI. Damage and developmental impairment of WM can result in devastating 
outcomes such as cerebral palsy, long-term cognitive impairment, and other deficits (1). Our 
data in the lateral caudate region (which included a portion of corpus callosum, a region 
containing abundant WM) showed that TH provides protection from WMI. This data is 
consistent with previous studies that show that TH reduces WMI in mice and sheep (17, 18). 
However, in the caudate region, analysis of MBP presence in relation to the degree of injury 
also shows that TH preserves WM from mild injury but not from severe injury.
The hippocampus is selectively vulnerable over the cortex and striatum in the HI murine 
model used here, and there is no significant WM protection in most hippocampal regions, 
but qualitative data suggest protection in penumbral regions of the hippocampus (CA2/3). 
The severe injury seen in this region may be resistant to the benefits of TH in this model (20, 
21). These data are consistent with previous studies that demonstrated that TH-mediated 
attenuation of caspase-dependent pathway activation after HI in neonatal mice is region-
specific (8) and that TH was neuroprotective in the HI-induced penumbra, but not in the 
core, and that protective effect was associated with a TH-induced increase of antioxidant 
enzymes SOD-1 and GPx, leaving several inflammatory mediators unchanged, including 
IL1β and MMP-9 (22). Another possibility is that the inflammatory response is strongest in 
the hippocampus, as evident from the Iba1 and GFAP coverage of microglia and astrocytes 
respectively, thus preferentially affecting oligodendrocytes in that region (23). Also, the 
hippocampus is distinct from other parenchymal regions due to its proximity to the 
cerebrovascular spaces and likely exposure to leukocytes in such spaces. This region has the 
most disturbed blood-brain barrier in the model we are using (24).
Hypothermic protection is a complex process and there is no consensus on the best protocol 
to achieve beneficial effect. Several groups showed that hypothermia induced immediately 
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after HI in P7 rats (body temperature 30°C Vs. 36°C for 10 h) provided protection and 
inhibition of caspase activation, thereby preventing apoptotic cell death (25). Even delayed 
cooling of P7 rats (rectal temperature 37°C Vs. 30°C for 26 h) starting 2 h after HI not only 
significantly reduced the final size of infarction (hippocampus and, to a lesser extent, cortex) 
6 weeks after the insult, but led to long-lasting behavioral improvement throughout brain 
maturation despite the severity of injury (26). TH during the HI insult significantly reduced 
spatial learning deficits (27). On the other hand, many studies have shown that by itself 
hypothermia did not protect against HI unless it was combined with adjunctive therapies, 
such as topiramate (28) or phenobarbital (29). Furthermore, addition of agents such as 
bumetanide (a NKCC1 transporter inhibitor) augmented the neuroprotective efficacy of 
phenobarbital combined with hypothermia (30), demonstrating that limiting multiple 
pathophysiological mechanisms may be needed to provide benefits. Yet, combination of Epo 
with TH showed no benefit over Epo alone after HI (7). Studies in larger animals (31) have 
also proven that TH can provide neuroprotection after HI, but, like in humans, that the 
severity of injury and timing, depth and duration of hypothermia are major variables. In 
sheep, significant protection was achieved by initiation of hypothermia at early timepoints, 
but protection is lost with delay for more than 8 hours, and prolongation of TH was not 
beneficial (32).
Currently, TH is the standard care for the treatment of HIE in neonates but protection of 
term infants is incomplete (33–36). This study shows that in a full-term murine model, TH 
has a significant effect in reducing the injury of mice susceptible to HI, supportive of current 
studies. However, the severity of injury from HI still cannot be predicted, and the variability 
in the degree of injury has a relationship with the protective effects of TH. Sex stratification 
did not show differences in our study, yet a previous study in P10 mice with HI showed that 
post-TH male mice showed neuroprotection, while the females had variable degrees of 
injury and protective effects could not be observed (17).
One limitation of this study is a variable degree of injury in individual pups. Variability in 
injury has been a consistent limitation noted in various murine HI studies, with severe/
extensive injury providing the greatest challenge to access TH protection (4, 8, 17). Severe 
injury in some pups precluded us from systematically quantifying the data. The degree of 
damage caused by HI, along with the heterogeneity of the neuroanatomy studied, provides 
challenges in analysis of these regions. Imaging modalities such as MRI has been suggested, 
and may provide an opportunity to better characterize and stratify the variability of injury.
HI initiates an inflammatory response, which potentiates and exacerbates neural damage 
(37). The presence of astrocytosis, as seen by GFAP immunolabeling, and microgliosis, as 
seen by Iba1 immunolabeling, are common findings in HI injury and support the role of 
neuroinflammation (38, 39). Our correlation analysis of the relationship between injury 
score and the inflammatory markers show significant regional inflammation protection by 
TH, even in the hippocampus in severely injured brains. These findings provide an 
opportunity for further investigation of therapy to prevent injury from HI, as inflammatory 
mediators have been suggested to play a role in injury due to HI in the neonatal brain (40). 
TH with adjunctive use of anti-inflammatory mediators could possibly provide significant 
protection from HI injury. A recent review showed that numerous immunomodulatory 
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therapies attenuating neuroinflammation show effective results in experimental models (41), 
supporting the use of these immunomodulating therapies with TH in a clinical setting of 
neonatal HI to prevent further neuronal injury.
Our data on effects of TH on microglial and astroglial coverage support a relationship 
between the glial coverage and injury, as we observed TH-induced protection in regions with 
reduced glial coverage and not in regions with unaffected glial coverage. It was long 
believed that glial cell activation associated with HI is necessarily injurious and that TH is 
protective by limiting or even aborting microglial accumulation. More recent studies in P7 
rats and P9 mice subjected to focal stroke have demonstrated that microglial in fact 
contribute to endogenous protective mechanisms (42, 43) and that the microglial 
phenotypes, rather than microglial number, determine destructive or protective features of 
these cells. Combining melatonin with TH after HI in a piglet model of perinatal asphyxia 
protected grey and WM, but did not change microglial numbers, but affected the expression 
of cytotoxic molecules in microglia (44).
Conclusion
Our study shows that TH displays a significant effect in reducing the injury and 
inflammation in a P9 murine HI model. Protection from WMI is evident, with mildly injured 
brains showing the greatest benefit and overall more influential neuroprotection. Qualitative 
data suggest that even the penumbral hippocampal region may be protected from HI with 
TH. Overall these data indicate regional differences in WMI susceptibility and inflammation 
in a P9 murine HI model. Inability to score highly injured brains quantitatively and a wide-
range of injury was a constraint. Standardization of HI injury would provide a greater 
opportunity to investigate the full-effects of TH regarding WMI and inflammation.
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Histopathological analysis injury score of brain samples. Filled data points indicate samples 
that were also used for ICC analysis. Cresyl violet staining of ipsilateral hemisphere for 
histopathological scoring of brain sections completed blindly of all samples. Sections were 
scored rostral to caudal at: anterior cortex, middle cortex, posterior cortex, caudate/striatum, 
hippocampus CA1, CA2, and CA3, and the dentate gyrus. Scoring was performed following 
protocol (Ferriero et. al., 1995): 0 = no injury; 1 = minimal cell loss, scattered shrunken 
neurons and glia; 2 = moderate cell loss; 3 = severe cell loss and gliosis with cystic 
infarction. Samples were compared according to treatment group: normothermia and 
hypothermia.
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MBP, GFAP, Iba1 coverage of medial caudate. MBP (green), GFAP (far red), Iba1 (red). 
Column (a) contains samples treated with HI + normothermia. Column (b) contains samples 
treated with HI + hypothermia. (c) Volumetric measurements normalized using the ratio of 
intact ipsilateral tissue to intact contralateral hemisphere tissue. Data comparing HI treated 
with normothermia and HI treated with hypothermia using a box-and-whisker graph. The 
horizontal line indicates the median score. Magnification is 10 X Scale bar = 100 um
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MBP, GFAP, Iba1 coverage of lateral caudate with corpus callosum. MBP (green), GFAP 
(far red), Iba1 (red). Column (a) contains samples treated with HI + normothermia. Column 
(b) contains samples treated with HI + hypothermia. (c) Volumetric measurements 
normalized using the ratio of intact ipsilateral tissue to intact contralateral hemisphere tissue. 
Data comparing HI treated with normothermia and HI treated with hypothermia using a box-
and-whisker graph. The horizontal line indicates the median score. Magnification is 10X. 
Scale bar = 100 um.
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MBP, GFAP, Iba1 coverage of hippocampus CA1 with dentate gyrus. MBP (green), GFAP 
(far red), Iba1 (red). Column (a) contains samples treated with HI + normothermia. Column 
(b) contains samples treated with HI + hypothermia. (c) Volumetric measurements 
normalized using the ratio of intact ipsilateral tissue to intact contralateral hemisphere tissue. 
Data comparing HI treated with normothermia and HI treated with hypothermia using a box-
and-whisker graph. The horizontal line indicates the median score. Magnification is 10X. 
Scale bar = 100 um.
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MBP, GFAP, Iba1 coverage of hippocampal regions CA2 and CA3. MBP (green), GFAP (far 
red), Iba1 (red). Column (a) contains samples treated with HI + normothermia. Column (b) 
contains samples treated with HI + hypothermia. (c) Volumetric measurements normalized 
using the ratio of intact ipsilateral tissue to intact contralateral hemisphere tissue. Data 
comparing HI treated with normothermia and HI treated with hypothermia using a box-and-
whisker graph. The horizontal line indicates the median score. Magnification is 10X. Scale 
bar =100 um
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Correlation coefficients between injury score and volumetric raw data measurements. 
Normothermic (circles); hypothermic (squares). The relationship between the raw 
volumetric data of: MBP, GFAP and Iba1; and injury was used to determine a correlation 
coefficient. Caudate and hippocampal regions were evaluated. (a) MBP volumetric 
measurements of caudate regions compared to injury score. Normothermic r = −0.4668 and 
hypothermic r = −0.9077. (b) GFAP volumetric measurements of caudate regions compared 
to injury score. Normothermic r = 0.9128 and hypothermic r = 0.2448. (c) Iba1 volumetric 
measurements of caudate regions compared to injury score. Normothermic r = 0.7524 and 
hypothermic r = 0.4958. (d) MBP volumetric measurements of hippocampal regions 
compared to injury score. Normothermic r = −0.3066 and hypothermic r = −0.08531. (e) 
GFAP volumetric measurements of hippocampal regions compared to injury score. 
Normothermic r = 0.4062 and hypothermic r = −0.2900. (f) Iba1 volumetric measurements 
of hippocampal regions compared to injury score. Normothermic r = 0.4475 and 
hypothermic r = −0.3770.
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